Review discusses advances in noninvasive point-of-care diagnostics for infectious and neurodegenerative diseases, suggesting benefits of oral fluid testing.
Widespread and simple detection of diseases and disfunctions in the body is crucial for reliable and prompt diagnostics, efficient use of healthcare resources, and improved quality of life. The presence of a large number of metabolic products in saliva, the relationship between their levels in saliva and blood, the diagnostic value of many of these compounds, and the advantages of noninvasive sampling drive interest in oral fluid as a biomatrix. This review summarizes established oral fluid biomarkers, as well as potential salivary indicators for remote health monitoring and noninvasive point-of-care diagnostics. Recent advances in the search for new solutions for sensitive and high-throughput immunodetection of biomarkers in oral fluid are discussed, along with strategies for overcoming the analytical and technical challenges associated with the salivary matrix testing. Another focus of the current review is optical and electrochemical immunosensors with an emphasis on lateral flow immunoassays for point-of-care testing due to their speed, simplicity and cost-effectiveness. Finally, future directions are discussed that may enable non-invasive monitoring of endocrine, infectious, immune, neurodegenerative diseases and other human conditions using immunoassay platforms, paving the way for personalized and accessible healthcare.
No takes yet. Share an insight, caveat, or question.
Serebrennikova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: